Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Equity Ratio (2016 - 2025)

OptimizeRx's Equity Ratio history spans 16 years, with the latest figure at 0.72 for Q3 2025.

  • For Q3 2025, Equity Ratio rose 3.6% year-over-year to 0.72; the TTM value through Sep 2025 reached 0.72, up 3.6%, while the annual FY2024 figure was 0.68, 0.96% down from the prior year.
  • Equity Ratio for Q3 2025 was 0.72 at OptimizeRx, up from 0.7 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.96 in Q1 2021 and bottomed at 0.68 in Q4 2024.
  • The 5-year median for Equity Ratio is 0.94 (2022), against an average of 0.84.
  • The largest annual shift saw Equity Ratio grew 23.11% in 2021 before it decreased 26.67% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.93 in 2021, then grew by 0.51% to 0.94 in 2022, then decreased by 26.31% to 0.69 in 2023, then fell by 0.96% to 0.68 in 2024, then rose by 5.02% to 0.72 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Equity Ratio are 0.72 (Q3 2025), 0.7 (Q2 2025), and 0.69 (Q1 2025).